JUL 14, 2020 10:47 PM PDT

Antiplatelet Drug Shows Promise for Heart Attack Treatment

WRITTEN BY: Nouran Amin

A common and often dangerous side-effect of antiplatelet medications is an increase in bleeding. As such, researchers at the University of Illinois at Chicago created a therapeutic that will prevent blood clots without the chance of increased bleeding.

"Unfortunately, current antiplatelet medications prevent the blood clotting that cause heart attack and stroke but also disrupt platelets' ability to stop bleeding if a blood vessel is torn," says Xiaoping Du, a UIC professor of pharmacology and regenerative medicine at the College of Medicine who led the research. "In some cases, severe bleeding can be life-threatening. The magic of this new drug is it prevents clots but does not make people prone to bleeding, which other drugs have failed to do."

Findings were published in the journal Science Translational Medicine describes the peptide-derived nanoparticle drug called ‘M3mP6’ and can treat heart attacks in mice. The results confirm the drug's capability in reducing clotting and inflammation.

Learn more about antiplatelet medication:

Researchers were able to test the efficacy and safety of the drug in mouse models and administer the therapeutic via injection. They found that the mice had an overall improved survival as a result of improved heart function.

"It is very exciting to see such promising results in the lab and we hope to one day test this in humans," Du said.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 14, 2021
Health & Medicine
A National Standard THC Dose for Researchers is Here
MAY 14, 2021
A National Standard THC Dose for Researchers is Here
    Whatever your stance on cannabis, almost  everyone would agree that more, better quality, research sh ...
MAY 22, 2021
Drug Discovery & Development
FDA Approves Trials for Ketamine to Treat Parkinson's
MAY 22, 2021
FDA Approves Trials for Ketamine to Treat Parkinson's
The US FDA has approved PharmaTher’s Investigational New Drug application to begin Phase 2 clinical trials for ket ...
JUN 21, 2021
Cardiology
Researchers Find Evidence That Gut Microbes Affect Stroke Severity
JUN 21, 2021
Researchers Find Evidence That Gut Microbes Affect Stroke Severity
Research has indicated that there is a connection between gut microbes and heart health. Now scientists are revealing so ...
JUN 24, 2021
Cell & Molecular Biology
The Curiosity About Caterpillar Venom
JUN 24, 2021
The Curiosity About Caterpillar Venom
It seems like Australia is home to some of the world's deadliest animals, like taipan snakes and box jellyfish. Even the ...
JUN 29, 2021
Microbiology
Gut Fungi May Be an Untapped Reservoir of Antibiotics
JUN 29, 2021
Gut Fungi May Be an Untapped Reservoir of Antibiotics
Viruses are not the only microbes that can cause serious public health problems. Researchers have been warning about a p ...
JUL 20, 2021
Technology
Artificial Intelligence Predicts Which Drug Candidates Will Be Successful In Clinical Trials
JUL 20, 2021
Artificial Intelligence Predicts Which Drug Candidates Will Be Successful In Clinical Trials
Researchers are leveraging artificial intelligence and machine learning to help improve the rate at which drugs move suc ...
Loading Comments...